HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Liao Selected Research

Continuous Passive Motion Therapy

7/2014Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.
1/2012Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Liao Research Topics

Disease

18Neoplasms (Cancer)
04/2022 - 07/2013
6Myocardial Infarction
11/2021 - 04/2009
5Infections
02/2022 - 03/2015
5Inflammation (Inflammations)
02/2022 - 01/2020
5Brain Ischemia (Cerebral Ischemia)
01/2021 - 10/2014
4Stroke (Strokes)
12/2021 - 03/2002
4Spondylosis
08/2017 - 07/2012
3Lung Neoplasms (Lung Cancer)
05/2022 - 12/2020
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
02/2022 - 05/2020
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2021
3Fibrosis (Cirrhosis)
11/2021 - 07/2012
3Intervertebral Disc Degeneration
12/2014 - 04/2013
2Rheumatoid Arthritis
07/2022 - 04/2011
2Breast Neoplasms (Breast Cancer)
04/2022 - 01/2017
2Disease Progression
02/2022 - 01/2021
2Acute Coronary Syndrome
01/2022 - 03/2020
2Cicatrix (Scar)
12/2021 - 01/2021
2Capsule Opacification
10/2021 - 01/2021
2Fever (Fevers)
09/2021 - 01/2020
2Reperfusion Injury
09/2021 - 01/2021
2Cardiovascular Diseases (Cardiovascular Disease)
05/2021 - 03/2020
2Drug-Related Side Effects and Adverse Reactions
01/2021 - 01/2021
2Adenocarcinoma
01/2021 - 01/2021
2Ischemic Stroke
01/2021 - 01/2021
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2020 - 06/2015
2Mycoses (Diseases, Fungus)
12/2016 - 03/2015
2Infarction (Infarctions)
10/2016 - 10/2010
2Non-Muscle Invasive Bladder Neoplasms
07/2015 - 07/2015
2Urinary Bladder Neoplasms (Bladder Cancer)
07/2015 - 03/2015
2Venous Thromboembolism
07/2014 - 01/2012
2DiGeorge Syndrome (Syndrome, DiGeorge)
08/2010 - 04/2008
1Carcinoma in Situ
04/2022
1Residual Neoplasm
04/2022
1Infectious Arthritis (Septic Arthritis)
02/2022
1Arthritis (Polyarthritis)
02/2022
1Nausea
01/2022
1Vomiting
01/2022
1Gliosis
12/2021
1Migraine Disorders (Migraine)
10/2021

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
02/2022 - 01/2014
7Proteins (Proteins, Gene)FDA Link
02/2022 - 07/2013
5CollagenIBA
01/2021 - 01/2013
4naotaifangIBA
01/2021 - 06/2015
3AntigensIBA
12/2021 - 01/2014
3AlkaloidsIBA
12/2021 - 07/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2021 - 10/2014
3CateninsIBA
12/2020 - 12/2014
3VaccinesIBA
01/2020 - 03/2015
2Anti-Citrullinated Protein AntibodiesIBA
07/2022 - 04/2011
2MicroRNAs (MicroRNA)IBA
05/2022 - 03/2015
2Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2022 - 07/2013
2FlavonoidsIBA
02/2022 - 01/2018
2Arachidonic Acid (Vitamin F)IBA
02/2022 - 10/2020
2Messenger RNA (mRNA)IBA
02/2022 - 06/2015
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2021 - 10/2020
2Long Noncoding RNAIBA
01/2021 - 01/2020
2Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 07/2013
2Biological ProductsIBA
12/2020 - 08/2015
2IronIBA
07/2020 - 06/2015
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2014
2Serotonin (5 Hydroxytryptamine)IBA
09/2019 - 01/2010
2Matrix Metalloproteinases (MMPs)IBA
08/2017 - 12/2013
2IntegrinsIBA
06/2016 - 12/2014
2DNA (Deoxyribonucleic Acid)IBA
01/2016 - 01/2014
2metal transporting protein 1 (ferroportin)IBA
01/2016 - 06/2015
2Cyclin D1IBA
03/2015 - 07/2013
2nitidineIBA
09/2014 - 07/2013
2Angiotensin IIIBA
01/2014 - 01/2010
2Transcription Factors (Transcription Factor)IBA
08/2010 - 04/2008
1Peptides (Polypeptides)IBA
07/2022
1interleukin-21 (interleukin 21)IBA
02/2022
1BerberineIBA
02/2022
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2022
1Lipoxygenase (Lipoxygenase-1)IBA
02/2022
1osimertinibIBA
01/2022
1PlatinumIBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2022
1Clopidogrel (Plavix)FDA Link
01/2022
1Janus KinasesIBA
12/2021
1NivolumabIBA
12/2021
1Nitroglycerin (Dynamite)FDA LinkGeneric
10/2021
1HydrogelsIBA
10/2021
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
10/2021

Therapy/Procedure

13Therapeutics
01/2022 - 07/2012
6Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2022 - 06/2015
4Drug Therapy (Chemotherapy)
01/2022 - 01/2014
4Electroacupuncture
12/2014 - 07/2012
3Lasers (Laser)
07/2015 - 05/2015
2Intraocular Lenses (Intraocular Lens)
10/2021 - 01/2021
2Knee Replacement Arthroplasty (Total Knee Replacement)
07/2014 - 01/2012
2Continuous Passive Motion Therapy
07/2014 - 01/2012
1Neoadjuvant Therapy
04/2022
1Percutaneous Coronary Intervention
01/2022
1Adjuvant Chemotherapy
01/2022
1Stroke Rehabilitation
12/2021
1Neurological Rehabilitation
12/2021
1Drug Administration Schedule
12/2021
1Tissue and Organ Harvesting
10/2021